<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been postulated that <z:chebi fb="105" ids="17234">glucose</z:chebi> transport is the principal site of skeletal muscle <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, though a distribution of control between <z:chebi fb="105" ids="17234">glucose</z:chebi> transport and phosphorylation has also been proposed </plain></SENT>
<SENT sid="1" pm="."><plain>The current study examined whether the respective contributions of transport and phosphorylation to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> are modulated across a dose range of insulin stimulation </plain></SENT>
<SENT sid="2" pm="."><plain>Rate constants for transport and phosphorylation in skeletal muscle were estimated using dynamic <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography (PET) imaging of 2-deoxy-2[<z:chebi fb="0" ids="36939">18F</z:chebi>]fluoro-<z:chebi fb="0" ids="4167">D-glucose</z:chebi> ([<z:chebi fb="0" ids="36939">18F</z:chebi>]FDG) during insulin infusions at three rates (0, 40, and 120 mU/m2 per min) in lean <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant, <z:mp ids='MP_0001261'>obese</z:mp> <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant, and <z:mp ids='MP_0001261'>obese</z:mp> type 2 diabetic subjects </plain></SENT>
<SENT sid="3" pm="."><plain>Parallel studies of arteriovenous fractional extraction across the leg of [<z:chebi fb="0" ids="36939">18F</z:chebi>]FDG and [2-3H] <z:chebi fb="105" ids="17234">glucose</z:chebi> were performed to measure the "lumped constant" (LC) (i.e., the analog effect) for [<z:chebi fb="0" ids="36939">18F</z:chebi>]FDG to determine whether this value is affected by insulin dose or <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The value of the LC was similar across insulin doses and groups </plain></SENT>
<SENT sid="5" pm="."><plain>Leg <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake (LGU) also provided a measure of skeletal muscle <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism independent of PET </plain></SENT>
<SENT sid="6" pm="."><plain>[<z:chebi fb="0" ids="36939">18F</z:chebi>]FDG uptake determined by PET imaging strongly correlated with LGU across groups and across insulin doses (r = 0.81, P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Likewise, LGU correlated with PET parameters of <z:chebi fb="105" ids="17234">glucose</z:chebi> transport (r = 0.67, P &lt; 0.001) and <z:chebi fb="105" ids="17234">glucose</z:chebi> phosphorylation (r = 0.86, P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> transport increased in response to insulin in the lean and <z:mp ids='MP_0001261'>obese</z:mp> groups (P &lt; 0.05), but did not increase significantly in the type 2 diabetic group </plain></SENT>
<SENT sid="9" pm="."><plain>A dose-responsive pattern of stimulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> phosphorylation was observed in <z:hpo ids='HP_0000001'>all</z:hpo> groups of subjects (P &lt; 0.05); however, <z:chebi fb="105" ids="17234">glucose</z:chebi> phosphorylation was lower in both the <z:mp ids='MP_0001261'>obese</z:mp> and type 2 diabetic groups compared with the lean group at the moderate insulin dose (P &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>These findings indicate an important interaction between transport and phosphorylation in the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> of <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>